To validate the results of the experimental model, and to demonstrate increased SgII levels also in chronic, stable HF, circulating SgII levels in 58 patients with chronic HF were compared to levels in 20 age- and gender-matched healthy control subjects (Table 2). This evidence concerns the gene SCG2 and hydrops fetalis.